Sökning: id:"swepub:oai:gup.ub.gu.se/59479" >
Follow-up of low-ri...
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective.
-
Schlumberger, Martin (författare)
-
- Berg, Gertrud, 1944 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för särskilda specialiteter, Avdelningen för onkologi,Institute of Selected Clinical Sciences, Department of Oncology
-
Cohen, Ohad (författare)
-
visa fler...
-
Duntas, Leonidas (författare)
-
Jamar, François (författare)
-
Jarzab, Barbara (författare)
-
Limbert, Eduard (författare)
-
Lind, Peter (författare)
-
Pacini, Furio (författare)
-
Reiners, Christoph (författare)
-
Sánchez Franco, Franco (författare)
-
Toft, Anthony (författare)
-
Wiersinga, Wilmar M (författare)
-
visa färre...
-
(creator_code:org_t)
- 2004
- 2004
- Engelska.
-
Ingår i: European journal of endocrinology / European Federation of Endocrine Societies. - 0804-4643. ; 150:2, s. 105-12
- Relaterad länk:
-
https://gup.ub.gu.se...
Abstract
Ämnesord
Stäng
- OBJECTIVE: Because differentiated (follicular and papillary) thyroid cancer (DTC) may recur years after initial treatment, the follow-up of patients with DTC is long term. However, this population has changed, with more individuals being discovered at an earlier stage of the disease, so that previous follow-up protocols based mostly on data from high-risk patients no longer apply. We sought to develop an improved protocol for the follow-up of low-risk patients with DTC based on the findings of recent studies. METHODS: We analysed recent literature on the follow-up of DTC. RESULTS: Recent large studies have produced three important findings: (i) in patients with low-risk DTC with no evidence of disease up to the 6- to 12-month follow-up, diagnostic whole-body scan adds no information when serum thyroglobulin (Tg) is undetectable and interference from anti-Tg antibodies is absent; (ii) use of recombinant human thyroid-stimulating hormone to aid Tg measurement is effective and provides greater safety, quality-of-life and work productivity than does levothyroxine withdrawal with its attendant hypothyroidism; and (iii) ultrasonography performed by an experienced operator is the most sensitive means of detecting neck recurrences of DTC. CONCLUSIONS: We present a revised follow-up protocol for low-risk patients taking into account the above findings. This protocol should help clinicians enter a new era of monitoring characterized by greater safety, simplicity, convenience and cost savings.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Adenocarcinoma
- Follicular
- blood
- diagnosis
- secondary
- therapy
- Carcinoma
- Papillary
- blood
- diagnosis
- secondary
- Clinical Protocols
- standards
- Decision Trees
- Europe
- Follow-Up Studies
- Lymphatic Metastasis
- Neoplasm Recurrence
- Local
- blood
- ultrasonography
- Practice Guidelines
- Recombinant Proteins
- diagnostic use
- Risk
- Thyroglobulin
- blood
- diagnostic use
- Thyroid Neoplasms
- blood
- diagnosis
- therapy
- Treatment Outcome
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Schlumberger, Ma ...
-
Berg, Gertrud, 1 ...
-
Cohen, Ohad
-
Duntas, Leonidas
-
Jamar, François
-
Jarzab, Barbara
-
visa fler...
-
Limbert, Eduard
-
Lind, Peter
-
Pacini, Furio
-
Reiners, Christo ...
-
Sánchez Franco, ...
-
Toft, Anthony
-
Wiersinga, Wilma ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
European journal ...
- Av lärosätet
-
Göteborgs universitet